Technical Analysis for LPCN - Lipocine Inc.

Grade Last Price % Change Price Change
B 4.49 -2.39% -0.11
LPCN closed down 2.39 percent on Monday, March 18, 2024, on 39 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Spinning Top Other 0.00%
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Slingshot Bullish Bullish Swing Setup -2.39%
Calm After Storm Range Contraction -2.39%
Upper Bollinger Band Walk Strength -2.39%
Wide Bands Range Expansion -2.39%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 11 hours ago
Down 3% about 11 hours ago
Down 2 % about 11 hours ago
Down 1% about 11 hours ago
Upper Bollinger Band Resistance about 12 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lipocine Inc. Description

Lipocine Inc., a specialty pharmaceutical company, is engaged in the development of pharmaceutical products in the areas of men's and women's health. The company offers a portfolio of proprietary product candidates that are used to produce pharmacokinetic characteristics; facilitate lower dosing requirements and bypass first-pass metabolism; reduce side effects; and eliminate gastrointestinal interactions that limit bioavailability. Its product candidates for men's health include LPCN 1021, an oral product candidate, which is in Phase III clinical trials; and LPCN 1111, an oral product candidate that is in Phase I/II clinical trials for the treatment of testosterone replacement therapy. The company's product candidates for women's health comprise LPCN 1107, which is in Phase I/II clinical trials for the prevention of preterm birth. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Alcohol Pharmaceutical Products Gastrointestinal Clinical Research Clinical Trial Metabolism Bypass Ketones Testosterone Androstanes Preterm Birth

Is LPCN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.95
52 Week Low 2.3101
Average Volume 30,963
200-Day Moving Average 3.66
50-Day Moving Average 3.84
20-Day Moving Average 3.96
10-Day Moving Average 4.06
Average True Range 0.36
RSI (14) 65.28
ADX 28.87
+DI 30.91
-DI 16.88
Chandelier Exit (Long, 3 ATRs) 4.17
Chandelier Exit (Short, 3 ATRs) 4.29
Upper Bollinger Bands 4.69
Lower Bollinger Band 3.22
Percent B (%b) 0.86
BandWidth 37.15
MACD Line 0.18
MACD Signal Line 0.09
MACD Histogram 0.0911
Fundamentals Value
Market Cap 23.87 Million
Num Shares 5.32 Million
EPS -3.21
Price-to-Earnings (P/E) Ratio -1.40
Price-to-Sales 2.36
Price-to-Book 0.95
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.02
Resistance 3 (R3) 5.05 4.90 4.93
Resistance 2 (R2) 4.90 4.76 4.88 4.90
Resistance 1 (R1) 4.69 4.68 4.62 4.67 4.87
Pivot Point 4.54 4.54 4.50 4.53 4.54
Support 1 (S1) 4.34 4.41 4.26 4.31 4.11
Support 2 (S2) 4.19 4.32 4.17 4.08
Support 3 (S3) 3.98 4.19 4.05
Support 4 (S4) 3.96